MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    May substantia nigra volume asymmetry be an indicator of motor asymmetry in Parkinson’s disease? A retrospective analysis

    N.F. Durmaz, M. Yorubulut, C.M. Akbostanci (Ankara, Turkey)

    Objective: We investigated whether smaller substantia nigra is associated with worse parkinsonism on the corresponding contralateral side. Background: Degeneration of dopaminergic cells and morphologic changes…
  • 2016 International Congress

    Disruption of functional connectivity in Parkinson’s disease patients presenting phonemic fluency impairment

    K. Kawabata, H. Watanabe, E. Bagarinao, N. Yoneyama, K. Hara, R. Ohdake, K. Imai, M. Masuda, T. Yokoi, T. Tsuboi, M. Ito, N. Atsuta, M. Katsuno, G. Sobue (Nagoya, Japan)

    Objective: This study was designed to clarify the changes of detailed functional connectivity in association with phonemic fluency deficits in Parkinson's disease (PD) patients using…
  • 2016 International Congress

    Resting-state functional connectivity of subthalamic nucleus in different phenotypes of Parkinson’s disease

    Z. Wang, H. Chen, H. Ma, L. Ma, T. Wu, T. Feng (Beijing, People's Republic of China)

    Objective: To explore the different resting-state functional connectivity of subthalamic nucleus (STN) in different phenotypes of Parkinson's disease (PD). Background: The STN is one of…
  • 2016 International Congress

    Pronounced beta oscillations are a characteristic of the cortico-basal ganglia loop of subacute and chronic animal models of Parkinson´s disease

    C. van Riesen, J.K. Haumesser, J. Kühn, A. Kühn, M.H. Beck (Berlin, Germany)

    Objective: To compare the power spectral densities of local field potentials recorded from the cortico-basal ganglia loop of a subacute (reserpine) and a chronic (6-OHDA)…
  • 2016 International Congress

    Comparative analysis of clinical and neuroimaging features of parkinsonism and dementia of Alzheimer’s type

    D. Tolibov, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Explore the features of cognitive disorders and neuroimaging features of Parkinson's disease (PD) and Alzheimer's disease (AD) in the comparative aspect. Methods: Study 64…
  • 2016 International Congress

    Resting state functional connectivity in olfactory network in de novo Parkinson’s disease

    S. Marino, L. Bonanno, F. Caminiti, F. Corallo, V. Lo Buono, S. De Salvo, G. Di Lorenzo, P. Bramanti (Messina, Italy)

    Objective: To assess the pattern of RS functional connectivity in PD patients, related to olfactory psychometric test, to elucidate olfactory-dependent cortical-subcortical functional networks. Background: Olfactory…
  • 2016 International Congress

    A cognitive fMRI study of non-manifesting LRRK2 and GBA carriers

    A. Thaler, N. Bregman, A. Mirelman, T. Gurevich, M. Gana-Weiss, A. Orr-Urtreger, T. Hendler, N. Giladi (Tel-Aviv, Israel)

    Objective: To assess the cognitive profile of non-manifesting carriers of GBA and LRRK2 mutations using two fMRI tasks: a Stroop interference and N-Back working memory…
  • 2016 International Congress

    The association between structural brain connectivity with plasma APO-A1 levels in Parkinson’s disease: Connectometry approach

    F. Rahmani, M.H. Aarabi (Tehran, Islamic Republic of Iran)

    Objective: Features of the lipid profile specially cholesterol levels are association with PD risk. However no such data exists on the association of these plasma…
  • 2016 International Congress

    Cortical atrophy in cognitively impaired Parkinson’s disease patients

    M.M. Almuqbel, T.R. Melzer, D.J. Myall, M.R. MacAskill, L. Livingston, K. Wood, T.L. Pitcher, R.J. Keenan, J.C. Dalrymple-Alford, T.J. Andrson (Christchurch, New Zealand)

    Objective: To explore whether cognitive impairment in Parkinson's disease (PD) patients is associated with cortical thinning. Background: Parkinson's disease (PD) affects 1% of those over…
  • 2016 International Congress

    The role of cathepsin L involved in the activation of microglia and Parkinson’s disease

    S. Xu, X. Yang, H. Zhang, Y. Qian, Q. Xiao (Shanghai, People's Republic of China)

    Objective: To investigate the role of lysosomal protease cathepsin L in the activation of microglia and the injury of dopaminergic neurons, and further to interpret…
  • « Previous Page
  • 1
  • …
  • 1848
  • 1849
  • 1850
  • 1851
  • 1852
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley